FIELD: biotechnology.
SUBSTANCE: invention relates to recombinant polypeptides with phospholipase C activity, and can be used for degumming oils and fats. Disclosed is phospholipase C mutant polypeptide, amino acid sequence of which is at least 95% identical to SEQ ID NO: 4 and is characterized by the presence of proline, valine, serine and serine in positions of amino acid residues, corresponding to positions 6, 8, 10 and 104 in SEQ ID NO: 4 respectively.
EFFECT: invention provides obtaining mutant phospholipase C with high enzymatic activity, which improves efficiency of degumming and increases output of diacylglycerol (DAG) during degumming.
12 cl, 3 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| POLYPEPTIDE HAVING PHOSPHOLIPASE C ACTIVITY, AND USE THEREOF | 2019 |
|
RU2819269C2 |
| NEW POLYPEPTIDE AND METHOD OF PRODUCING L-LEUCINE USING ITS | 2021 |
|
RU2811433C1 |
| METHOD FOR REDUCING ERRONEOUS INCLUSION OF NON-CANONICAL BRANCHED-CHAIN AMINO ACIDS | 2019 |
|
RU2816654C2 |
| MODIFIED POLYPEPTIDE WITH REDUCED CITRATE SYNTHASE ACTIVITY AND A METHOD FOR PRODUCING THE L-AMINO ACID USING THE POLYPEPTIDE | 2019 |
|
RU2732815C1 |
| ANTIBODY TO HUMAN CD73 | 2017 |
|
RU2754058C2 |
| EXPRESSION OF NITROGENASE POLYPEPTIDES IN PLANT CELLS | 2018 |
|
RU2809244C2 |
| POLYPEPTIDES THAT ARE SOLUBLE RECEPTORS OF FIBROBLAST GROWTH FACTOR 3 (sFGFR3), AND WAYS OF THEIR APPLICATION | 2017 |
|
RU2751483C2 |
| CD73 BLOCKING ANTIBODIES | 2020 |
|
RU2819204C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER | 2018 |
|
RU2781116C1 |
| ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
